Leiden University Medical Center - Department of Medical Decision Making, Leiden, The Netherlands.
Best Pract Res Clin Rheumatol. 2012 Oct;26(5):721-31. doi: 10.1016/j.berh.2012.08.005.
Rheumatic disorders concern a broad spectrum of painful disorders affecting the musculoskeletal system, and are responsible for a considerable amount of disease burden and also a substantial economic burden. This economic burden consists of direct and indirect costs, but also the so-called intangible costs. In this study, we estimated the societal cost of rheumatic disorders in the Netherlands, including intangible costs. Data from the National Monitor on Musculoskeletal System 2010 were used to assess resource used, multiplied with standard prices for the Netherlands to obtain total costs for the 1.8 million people suffering from rheumatic disorders. These estimates were supplemented with data from secondary sources. Total societal costs of rheumatic disorders in the Netherlands amount to €4.7 million a year, that is, €2665 per person with rheumatic disorders. Rheumatic disorders have considerable costs, which justify more attention in discussing investments in facing the challenges in our ageing Western societies.
风湿性疾病涉及广泛的影响肌肉骨骼系统的疼痛性疾病,是导致相当大疾病负担和经济负担的主要原因。这种经济负担包括直接和间接成本,还有所谓的无形成本。在这项研究中,我们估计了荷兰风湿性疾病的社会成本,包括无形成本。使用 2010 年国家肌肉骨骼系统监测的数据来评估所使用的资源,乘以荷兰的标准价格,以获得 180 万患有风湿性疾病的人的总费用。这些估计数还补充了来自二手资料的数据。荷兰风湿性疾病的社会总成本为每年 470 万欧元,即每位风湿性疾病患者 2665 欧元。风湿性疾病的成本相当高,这证明在讨论投资以应对我们老龄化的西方社会所面临的挑战时,应该给予更多关注。